T2 Biosystems

T2 Biosystems, Inc. is a medical technology company based in Lexington, Massachusetts, founded in 2006. The company specializes in developing rapid diagnostic solutions for critical infections, aiming to meet significant healthcare needs. The core innovation of T2 Biosystems is its T2MR Technology, which utilizes magnetic resonance technology for direct pathogen detection from patient samples without the need for blood culture. This technology delivers results within 3-5 hours, greatly reducing the time required for diagnosis compared to traditional methods. The company offers a range of diagnostic panels, including the T2Dx Instrument Platform, T2Bacteria Panel, T2Candida Panel, T2SARS-CoV-2 Panel, and T2Resistance Panel, all designed to enhance the speed and accuracy of infectious disease detection. T2 Biosystems is committed to improving patient outcomes by enabling rapid diagnostic testing for bloodstream infections, allowing for quicker treatment initiation. The company is publicly traded on NASDAQ under the ticker symbol TTOO.